Interim results from a large multinational extension trial (guardian2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

S. R. Lentz, M. Cerqueira, D. Janic, C. Kempton, I. Matytsina, M. Misgav, J. Oldenburg, M. Ozelo, M. Recht, A. Rosholm, A. Savic, T. Suzuki, A. Tiede, E. Santagostino

Research output: Contribution to journalLetterpeer-review

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)e445-e449
Issue number5
StatePublished - Sep 1 2016

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)

Cite this